Nursing Elites

1. What is a genetic disorder that affects the lungs and digestive system, leading to thick, sticky mucus that can clog the airways?

• A. Cystic fibrosis
• B. COPD
• C. Bronchiectasis
• D. Pulmonary fibrosis

Correct answer: A

Rationale: The correct answer is A, cystic fibrosis. Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system. It leads to the production of thick, sticky mucus that can clog the airways, causing respiratory issues. Choice B, COPD (Chronic Obstructive Pulmonary Disease), is a different condition usually caused by smoking or exposure to irritants. Choice C, bronchiectasis, involves the widening and scarring of the airways, not the production of thick mucus. Choice D, pulmonary fibrosis, is a lung disease characterized by scarring of the lung tissue, not excessive mucus production.

2. What is a condition where the alveoli are gradually destroyed, leading to shortness of breath and reduced oxygen exchange?

• A. Emphysema
• B. Pulmonary fibrosis
• C. Pulmonary edema
• D. Lung cancer

Correct answer: A

Rationale: The correct answer is A: Emphysema. Emphysema is a chronic lung condition where the alveoli (air sacs) in the lungs are damaged, reducing the surface area available for gas exchange. This destruction leads to symptoms like shortness of breath and reduced oxygen exchange. Choice B, pulmonary fibrosis, involves scarring and thickening of the lung tissue, not destruction of alveoli. Choice C, pulmonary edema, is the accumulation of fluid in the lungs, not destruction of alveoli. Choice D, lung cancer, is the uncontrolled growth of abnormal cells in the lungs, not destruction of alveoli.

3. A client on spironolactone (Aldactone) has a potassium level of 6.0 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer a potassium supplement.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct action for a client on spironolactone with a potassium level of 6.0 mEq/L is to hold the medication and notify the healthcare provider. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels, which are already high. Administering a potassium supplement (Choice B) would exacerbate the hyperkalemia. Continuing the spironolactone as ordered (Choice C) could lead to worsening hyperkalemia. Increasing the dose of spironolactone (Choice D) would be contraindicated in the presence of elevated potassium levels.

4. Which term refers to high blood pressure, a condition where the force of the blood against the artery walls is too high?

• A. Hypertension
• B. Hypotension
• C. Hyperlipidemia
• D. Diabetes

Correct answer: A

Rationale: The correct answer is A, Hypertension. Hypertension is a condition characterized by persistently high blood pressure, which increases the risk of heart disease and stroke. Choice B, Hypotension, refers to low blood pressure. Choice C, Hyperlipidemia, is the term for high levels of fats in the blood. Choice D, Diabetes, is a condition characterized by high blood sugar levels.

5. What is a condition where the heart muscle becomes thickened without an obvious cause, leading to a reduction in the heart's ability to pump blood?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Myocarditis

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is the correct answer. It is a condition characterized by the abnormal thickening of the heart muscle without an obvious cause, which impairs the heart's ability to effectively pump blood. Dilated cardiomyopathy (choice B) involves the enlargement and weakening of the heart chambers, not thickening. Restrictive cardiomyopathy (choice C) refers to the stiffening of the heart muscle, limiting its ability to fill properly. Myocarditis (choice D) is inflammation of the heart muscle usually caused by a viral infection, not thickening.

Similar Questions